Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MEETINGS - Medical Labelling (US) October 1998:

This article was originally published in Clinica

Executive Summary

IBC will hold a meeting on Medical Labelling in Florida on October 22-23. Labelling requirements in the US, the EU, Japan and Canada will be discussed as well as aspects of multilingual labelling; developing alternative language on labels; translation of labelling to meet medical device directive requirements; and a comparative analysis of US and EU approaches. Delegates will hear a case study on how a medical device manufacturer prepared for the CE marking deadline for products sold in Europe. Contact IBC in the US for more details. Tel: +1 508 481 6400. Fax: +1 508 481 7911.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT083151

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel